Rho

We are ready for #PAINWeek! Ben Vaughn and Todd Bertoch, MD report the promising results from Viatris' proof-of-concept dental pain studies as well as investigate SPIDs vs AUCs in two single-center clinical trials. The insights don't end there! Becky Baggett and Brennan Munley, Rho pain experts, will also be there to discuss broader implications, answer tough questions, and share their deep expertise. Check out Poster 104 and meet the team.

Most of us associate hair loss with alopecia areata, but did you know about the emotional toll this condition can take on those affected? A study referenced by the National Alopecia Areata Foundation indicates that alopecia areata patients have "up to 38% higher risk of new-onset depression or anxiety." This serves as a powerful reminder for ongoing research and signals a call for action for us all to support the mental and emotional well-being of those living with alopecia areata. https://lnkd.in/exCft8yQ

A recent article published in JAMA Dermatology explores the broader impacts of alopecia areata beyond hair loss, shedding light on its effects on mental health. Our Principal Medical Director, Jamison Chang, MD weighs in. Check out the article: Immune-Mediated and Psychiatric Comorbidities Among Patients Newly Diagnosed With Alopecia Areata | Dermatology | JAMA Dermatology | JAMA Network

Our team of experts may not be Olympians (yet), but they sure know how to tackle the pain hurdles! Proud to have such a talented group representing us at #IASP. #RhoExpertsinAction

SUN PHARMA is shining brightly! We are thrilled to see LEQSELVI (deuruxolitinib) receive FDA approval as a new treatment for adults with severe alopecia areata. This achievement is a testament to Sun Pharma’s commitment to advancing healthcare and offering innovative solutions. We are proud to be a part of this significant milestone, bringing another important treatment option for patients with this disease. Kudos to everyone involved!  https://lnkd.in/eQ7mx9rz

Thank you Concentric Analgesics, Inc. collaborators Ben Vaughn, David Leiman, MD, MBA and Harold Minkowitz, MD, for presenting vocacapsaicin clinical results today at #IASP.

We've been talking about Ben Vaughn's poster presentation at #IASP and for those who didn't see it, here's a snapshot of Ben in action. If passion and expertise in pain drug development were an Olympic sport, he'd be bringing home the gold. Check out the details here: https://lnkd.in/e9KzNEWN

Only 4 more days until #IASP! Our team is heading across the pond to beautiful Amsterdam. If you're at the conference, swing by the poster session Tuesday at 3:15PM to hear Ben Vaughn share the game changing results from Concentric Analgesics, Inc. latest innovation in pain medicine, plus Phase 2 results from total knee arthroplasty. Definitely worth your time! https://lnkd.in/e_k7VCmH

With the ongoing opioid crisis, developing safer and effective pain management solutions are more important than ever. The research from Concentric Analgesics, Inc., which we supported, has made it onto the cover of Anesthesiology magazine. There's a lot of buzz about the article and for good reason. Discover more about this revolutionary advancement and why it matters. https://t.co/KGRTEd1vg2

We're thrilled to have you all attending #IASP, sharing your expertise in pain protocols and fostering site relationships. We're proud of the work the team has accomplished and look forward to developing partnerships to advance clinical programs. See you in Amsterdam!